Further studies on pyrazolo[1′,5′:1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists-Reference-Cited by-同舟云学术

Further studies on pyrazolo[1′,5′:1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists

Published:2015-01 Issue: Volume:89 Page:32-41
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Giovannoni Maria Paola,Ciciani Giovanna,Cilibrizzi Agostino^ORCID,Crocetti Letizia,Daniele Simona,Di Cesare Mannelli Lorenzo,Ghelardini Carla,Giacomelli Chiara,Guerrini Gabriella,Martini Claudia,Trincavelli Maria Letizia,Vergelli Claudia

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference47 articles.

1. International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors;Fredholm;Pharmacol. Rev.,2001

2. International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update;Fredholm;Pharmacol. Rev.,2011

3. P1 and P2 purine and pyrimidine receptor ligands;Jacobson,2001

4. Structure and function of adenosine receptors and their genes;Fredholm;Naunyn-Schmied. Arch. Pharmacol.,2000

5. Adenosine receptors: new opportunities for futures drugs;Poulsen;Bioorg. Med. Chem.,1998

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Monoamine Oxidases by Pyridazinobenzylpiperidine Derivatives;Molecules;2024-06-28

2. Optimization of 4‐amino‐pyridazin‐3(2H)‐one as a valid core scaffold for FABP4 inhibitors;Archiv der Pharmazie;2023-07-30

3. PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes;International Journal of Molecular Sciences;2023-07-15

4. Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition;Pharmaceuticals;2022-10-28

5. Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets;Structural Chemistry;2022-02-11